miR-107 regulates tumor progression by targeting NF1 in gastric cancer
2016 · Scientific Reports · 69 citations
https://doi.org/10.1038/srep36531
N
Na Tong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
3.8K
Citations
37
h-index
84
i10-index
Na Tong is an academic researcher from University of Sydney. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Epigenetics and DNA Methylation. The author has an h-index of 37, co-authored 134 publications.
ORCID: 0000-0001-8514-1643Papers by this author
worksClinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients
2014 · Carcinogenesis · 65 citations
https://doi.org/10.1093/carcin/bgu189
Hsa-miR-196a2 Rs11614913 Polymorphism Contributes to Cancer Susceptibility: Evidence from 15 Case-Control Studies
2011 · PLoS ONE · 63 citations
https://doi.org/10.1371/journal.pone.0018108
ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case–control studies
2010 · Prostate Cancer and Prostatic Diseases · 37 citations
https://doi.org/10.1038/pcan.2010.6
FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls
2011 · BMC Cancer · 36 citations
https://doi.org/10.1186/1471-2407-11-84
Functional polymorphisms in<i>FAS, FASL</i>and<i>CASP</i>8 genes and risk of childhood acute lymphoblastic leukemia: a case–control study
2012 · Leukemia & lymphoma/Leukemia and lymphoma · 13 citations
https://doi.org/10.3109/10428194.2011.654117
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat